One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Homozygous familiar hypercholesterolemia: still a long way to go
Rosa MSánchez-HernándezaFernandoCiveirab
Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?
Mark AChiaabPearse AKeaneab
COVID-19 in Europe: new challenges for addressing vaccine hesitancy
EmilieKarafillakisaPierreVan DammebGreetHendrickxbHeidi JLarsonab
Anaemia in chronic kidney disease: what do new generation agents offer?
MarcelloTonelliaRaviThadhanib
Samuel K Roberts: illuminating history, racial bias, and public health
AarathiPrasad
A public health manifestoGO BIG: 20 Bold Solutions to Fix Our World, Ed Miliband, Vintage (2022), p. 352, £9·99, ISBN: 9781529112757
JessamyBagenal
Diabetes and race in the USA over the past century
ArleenTuchmana
Three-dose vaccination elicits neutralising antibodies against omicron
MaryWuaEmma CWallabEdward JCarraRuthHarveycHermaleighTownsleyabHarriet VMearsaLorinAdamscSvendKjaeraGavinKellyaScottWarchalaChelseaSawyeraCaitlinKavanaghaChristophe JQuevalaYentingNgaidEmineHatipogludKarenAmbroseaSteveHindmarshaRupertBealead…David LVBauera
Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis
DominicHeiningaAiden JPlanta
Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis – Authors' reply
Diederikvan de BeekaMatthijs CBrouweraUweKoedelbEmma CWallcd
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Tycho RTrompMDaMerel LHartgersPhDabProfG KeesHovinghPhDaAntonio JVallejo-VazPhDcdeProfKausik KRayFRCPcHandreanSoranMDfProfTomasFreibergerPhDghProfStefanoBertoliniMDiMarikoHarada-ShibaPhDjDirk JBlomPhDkProfFrederick JRaalPhDlMarinaCuchelPhDm
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey SHeierMDaArshad MKhananiMDbcCarlosQuezada RuizMDdeKarenBasuPhDfPhilip JFerroneMDgChristopherBrittainMBBSeMarta SFigueroaMDhHughLinMDeFrank GHolzMDiVaibhaviPatelBPharmjProfTimothy Y YLaiMDkDavidSilvermanMDjCarlRegilloMDlBalakumarSwaminathanMScmProfFrancescoViolaMDnoProfChui Ming GemmyCheungMDpProfTien YWongMDp
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Charles CWykoffMDaFrancisAbreuPhDbAnthony PAdamisMDbKarenBasuPhDcDavid AEichenbaumMDdeZdenkaHaskovaMDbHughLinMDbProfAnatLoewensteinMDfShaunMohanMDbProfIan APearceMDgProfTaijiSakamotoMDhPatricio GSchlottmannMDiDavidSilvermanMBChBjJennifer KSunMDkJohn AWellsMDlJeffrey RWillisMDbProfRaminTadayoniMDmn
Hearing but not understanding: word deafness from a brainstem lesion
Jacob MPogsonPhDabProfG MichaelHalmagyiMDa
Diagnostics for COVID-19: moving from pandemic response to control
ProfRosanna WPeelingPhDabProfDavid LHeymannMDaYik-YingTeoDPhilcProfPatricia JGarciaMDde
